These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
641 related items for PubMed ID: 11005642
1. Biochemical and biophysical conditions for blood clot lysis. Sabovic M, Blinc A. Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642 [Abstract] [Full Text] [Related]
2. Biochemical and biophysical conditions for blood clot lysis. Šabovič M, Blinc A. Pflugers Arch; 2000 Jan; 440(Suppl 1):R134-R136. PubMed ID: 28008511 [Abstract] [Full Text] [Related]
10. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator. Wootton DM, Popel AS, Alevriadou BR. Biotechnol Bioeng; 2002 Feb 15; 77(4):405-19. PubMed ID: 11787013 [Abstract] [Full Text] [Related]
12. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation. Hare TR, Gardell SJ. Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162 [Abstract] [Full Text] [Related]
13. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method]. Ogloblina OG, Saburova OS, Semenova OA, Belova LA. Biokhimiia; 1994 Jan 03; 59(1):62-8. PubMed ID: 7509643 [Abstract] [Full Text] [Related]
16. Flow through clots determines the rate and pattern of fibrinolysis. Blinc A, Kennedy SD, Bryant RG, Marder VJ, Francis CW. Thromb Haemost; 1994 Feb 03; 71(2):230-5. PubMed ID: 8191404 [Abstract] [Full Text] [Related]
20. The role of fibroblasts in organization and degradation of a fibrin clot. Mirshahi M, Azzarone B, Soria J, Mirshahi F, Soria C. J Lab Clin Med; 1991 Apr 03; 117(4):274-81. PubMed ID: 2010668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]